6-Chloro-2-(3,5-dimethoxyphenyl)pyridazin-3(2H)-one, 95.0%, 1g

3-Bromo-2-cyclopropylpyridine, 95.0%, 250mg

h-dapa-oh.hbr, 95.0%, 5g

({[1-(tert-butoxycarbonyl)piperidin-4-yl]carbonyl}amino)acetic acid methyl ester, 250mg

Boc-Tyr-OMe, 99.00%, 5g

N-(4-Hydroxyphenyl)-N-methyl-2-thienylformamide, 95.0%, 5g

2,4-Dichloro-3-fluoronitrobenzene, 95.0%, 100g

2-Phenyl-1H-imidazole, 95.0%, 500g

Escualeno, mínimo 90 %, para síntesis, 100 ml, envase de vidrio

(E)-ETHYL 4-OXOPENT-2-ENOATE, 95.0%, 5g

Methylcyclopentane>96.0%(GC)500mL

3-Chloro-2,4,5-trifluorobenzoic Acid>98.0%(GC)(T)25g

1,3,6-Trimethyl-1 H -pyrazolo[3,4- b ]pyridine-4-carboxylic acid, 95.0%, 25g